Simcor niacin/simvastatin: Phase III data

In the double-blind Phase III SEACOAST trial in >600 patients, Simcor met the primary endpoint of a significant reduction in non-HDL cholesterol vs. simvastatin alone. The study compared 1,000 mg of ...